Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for vincristine-induced polyneuropathy in children with cancer
IRCT20230827059268N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chemotherapy-induced peripheral neuropathy (CIPN) and polyneuropathy comparing Duloxetine with Placebo (2 arms). Primary endpoints: Change in polyneuropathy symptoms caused by vincristine, Pediatric modified Total Neuropathy Score and 1 more. Started Jun 2024; status: completed.
02
Drugs
duloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)polyneuropathy
Beyond the preview
Go deeper on IRCT20230827059268N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230827059268N1.